CXCL13 and melanoma: TLS co-infiltrating CD8+ T cells and CD20+ B cells enhanced survival in metastatic melanomas co-expressing CXCR5 and CXCL13, whereas B-cell-enriched melanomas were accompanied by increased levels of naive or memory T cells [35].